What evidence supports the Public Health Advisory?
Merck’s decision to withdraw Vioxx from the market is based on new data from a trial called APPROV trial. In the APPROV trial, Vioxx was compared to Placebo (sugar-pill). The purpose of the trial was to see if Vioxx 25mg was effective in preventing the recurrence of colon polyps. This trial was stopped early because there was an increased risk for serious cardiovascular events, such as heart attacks and strokes, first observed after 18 months of continuous treatment of Vioxx compared with Placebo. Keith Kleinick can give you information about a structured settlement if you are currently receiving compensation payments for a Vioxx case.
Merck’s decision to withdraw Vioxx from the market is based on new data from a trial called the APPROVe [ Adenomatous Polyp Prevention on VIOXX] trial. In the APPROVe trial, Vioxx was compared to placebo (sugar-pill). The purpose of the trial was to see if Vioxx 25 mg was effective in preventing the recurrence of colon polyps. This trial was stopped early because there was an increased risk for serious cardiovascular events, such as heart attacks and strokes, first observed after 18 months of continuous treatment with Vioxx compared with placebo.
